Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer



Status:Terminated
Conditions:Prostate Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:April 2002

Use our guide to learn which trials are right for you!

A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing
so they stop growing or die. Radioactive substances such as strontium-89 may relieve bone
pain associated with prostate cancer. It is not yet known whether chemotherapy is more
effective with or without strontium-89 in treating bone metastases.

PURPOSE: This randomized phase III trial is studying giving chemotherapy together with
strontium-89 to see how well it works compared to chemotherapy alone in treating patients
with prostate cancer that has spread to the bone.

OBJECTIVES:

- Compare the effectiveness, in terms of overall survival, of consolidation therapy with
or without strontium chloride Sr 89 after induction chemotherapy in patients with
androgen-independent prostate cancer.

OUTLINE: This is a randomized study. Patients are stratified according to type of induction
chemotherapy (KAVE vs prednisone and docetaxel), number of bony metastases (no more than 20
vs more than 20), Eastern Cooperative Oncology (ECOG) performance status (0-1 vs 2-3), and
use of zoledronate (yes vs no).

- Induction therapy: Patients receive 1 of 2 induction therapy regimens.

- Regimen A (KAVE): Patients receive doxorubicin IV over 24 hours on day 1 and oral
ketoconazole three times daily on days 1-7 of weeks 1, 3, and 5. Patients receive
vinblastine IV over 30 minutes on day 1 and oral estramustine three times daily on
days 1-7 of weeks 2, 4, and 6. Patients receive no treatment on weeks 7 and 8.
Treatment repeats every 8 weeks for at least 2 courses* in the absence of disease
progression or unacceptable toxicity.

NOTE: *Patients continue to receive oral ketoconazole three times daily until disease
progression.

- Regimen B (prednisone and docetaxel): Patients receive oral prednisone twice daily on
days 1-21 (days 1-14 of course 5 only) and docetaxel IV over 1 hour on day 1. Treatment
repeats every 21 days for at least 5 courses in the absence of disease progression or
unacceptable toxicity.

- Consolidation therapy: Patients with a prostate-specific antigen (PSA) response
(at least 50% decline in PSA level from baseline at week 16 OR at least 2 PSA
levels decreased at least 50% from baseline) are randomized to 1 of 2
consolidation treatment arms.

- Arm I: Patients receive doxorubicin IV over 24 hours once weekly for 6 weeks plus
strontium chloride Sr 89 IV once at the beginning of chemotherapy.

- Arm II: Patients receive doxorubicin as in arm I. Patients are followed every 4 weeks
until PSA progression and then every 3 months thereafter.

PROJECTED ACCRUAL: Approximately 480 patients (240 randomized) will be accrued for this
study within 48 months.

Inclusion Criteria:

1. Rising PSA on at least 2 occasions >1 week apart (minimum value of 5 ng/ml),
accompanied either by bone pain or, if the patient is asymptomatic, by a worsening
bone scan with new lesions over a period of <6 months

2. Patients on antiandrogens should be discontinued from flutamide or nilutamide for at
least 4 weeks and bicalutamide for 6 weeks; If progression is documented during this
time interval as in inclusion criterion # 1, patients are eligible

3. Osteoblastic metastases on bone scan or CT scan

4. Androgen-independent prostate adenocarcinoma

5. Castrate testosterone level testosterone must be continued

6. >/= 18 years of age

7. Life expectancy of greater than or equal to 12 weeks

8. Zubrod performance status
9. Patients must have normal organ and marrow function as defined below: Leukocytes
greater than 3,000/mcL Absolute neutrophil count greater than 1,500/mcL Platelets
greater than 100,000/mcL Total bilirubin less than or equal to 2X institutional upper
limit of normal AST(SGOT)/ALT(SGPT) less than or equal to 2X institutional upper
limit of normal

10. The patient must have the ability to understand and the willingness to sign a written
informed consent document

11. Participating subjects and their female partners agree to the use of adequate
contraception (hormonal or barrier method of birth control) prior to study entry and
for the duration of study participation

Exclusion Criteria:

1. History of allergic reactions attributed to compounds of similar chemical or biologic
composition to the agents used on this trial

2. Prior doxorubicin, or vinblastine in the KAVE arm and prior docetaxel in the
prednisone plus docetaxel arm. However, previous treatment using other secondary
hormonal agents (aminoglutethimide, diethylstilbesterol, estramustine), steroids
(dexamethasone, prednisone, hydrocortisone), angiogenesis inhibitors, gene therapy,
or immunotherapy are allowed

3. More than one prior cytotoxic treatment

4. Prior Sr-89 or Sm-153 treatment

5. Patients who have had chemotherapy, immunotherapy, or radiotherapy within 4 weeks (6
weeks for nitrosoureas or mitomycin C) prior to entering the study or those who have
not recovered from adverse events due to agents administered more than 4 weeks
earlier

6. Previous vagotomy or other conditions (such as pernicious anemia) associated with
achlorhydria. Patients with active peptic ulcer disease who still require regular use
of H2 blockers (such as cimetidine [Tagamet], ranitidine [Zantac], famotidine
[Pepcid], etc), proton pump inhibitors (omeprazole [Prilosec]), or antacids (Mylanta,
Maalox, Tums, etc) at week 16 of induction chemotherapy (option 1 only) might not be
suitable for randomization

7. Predominant visceral metastases in the liver, lungs, or brain

8. Symptomatic lymphadenopathy (scrotal or pedal edema) or significant local invasive
disease (hematuria)

9. Small cell carcinoma

10. Recent history of transient ischemic attacks (TIA) or myocardial infarctions (MI)
within 12 months, or active angina or claudication sufficient to limit activity

11. Active or likely to become active second malignancy (other than non-melanoma skin
cancer)

12. Uncontrolled inter-current illness: including, but not limited to, ongoing or active
infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac
arrhythmia, or psychiatric illness/social situations that would limit compliance with
study requirements
We found this trial at
40
sites
33 Villa Road, Suite 400
Greenville, South Carolina 29615
(864) 404-2045
CCOP - Greenville Cancer care in the last decade has made many advances. Most of...
?
mi
from
Greenville, SC
Click here to add this to my saved trials
7777 Forest Ln # C840
Dallas, Texas 75230
(972) 566-7000
Medical City Dallas Hospital If you have concerns for your health, that of a family...
?
mi
from
Dallas, TX
Click here to add this to my saved trials
2500 N. State St.
Jackson, Mississippi 39216
(601) 815-6802
University of Mississippi Cancer Clinic he Cancer Institute is home to the ACT Tobacco Treatment,...
?
mi
from
Jackson, MS
Click here to add this to my saved trials
701 Doctors Dr
Kinston, North Carolina 28504
(252) 559-2200
Kinston Medical Specialists offers comprehensive medical services for all ages. Whether it’s a case of...
?
mi
from
Kinston, NC
Click here to add this to my saved trials
Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center The Curtis and...
?
mi
from
Savannah, GA
Click here to add this to my saved trials
161 North Forge Street
Akron, Ohio 44304
(330) 375-7280
Summa Center for Cancer Care at Akron City Hospital Summa Health System is a leader...
?
mi
from
Akron, OH
Click here to add this to my saved trials
Barberton, Ohio 44203
?
mi
from
Barberton, OH
Click here to add this to my saved trials
1351 Kimberly Rd
Bettendorf, Iowa 52722
(563) 355-7733
Hematology Oncology Associates of the Quad Cities
?
mi
from
Bettendorf, IA
Click here to add this to my saved trials
Billings, Montana 59101
?
mi
from
Billings, MT
Click here to add this to my saved trials
?
mi
from
Billings, MT
Click here to add this to my saved trials
Billings, Montana 59107
?
mi
from
Billings, MT
Click here to add this to my saved trials
2900 12th Ave N Ste 160W
Billings, Montana 59101
(406) 238-6290
Hematology-Oncology Centers of the Northern Rockies - Billings The physicians and staff of Hematology-Oncology Centers...
?
mi
from
Billings, MT
Click here to add this to my saved trials
1101 N 27th St # 201
Billings, Montana 59101
(406) 237-3585
St. Vincent Healthcare Cancer Care Services The Sisters of Charity of Leavenworth, Kansas, founded St....
?
mi
from
Billings, MT
Click here to add this to my saved trials
931 Highland Blvd
Bozeman, Montana 59715
(406) 585-5070
Bozeman Deaconess Cancer Center Bozeman Deaconess Cancer Center provides the latest cancer technologies and treatment...
?
mi
from
Bozeman, MT
Click here to add this to my saved trials
400 S Clark St
Butte, Montana 59701
(406) 723-2616
St. James Healthcare Cancer Care The St. James Cancer Center is an integrated cancer treatment...
?
mi
from
Butte, MT
Click here to add this to my saved trials
?
mi
from
Davenport, IA
Click here to add this to my saved trials
555 East Cheves Street
Florence, South Carolina 29506
843-777-2000
McLeod Regional Medical Center McLeod Health, a regional presence and predominant healthcare organization, is dedicated...
?
mi
from
Florence, SC
Click here to add this to my saved trials
743 Spring St NE
Gainesville, Georgia 30501
770-219-9000
Northeast Georgia Medical Center Northeast Georgia Health System (NGHS) is a not-for-profit community health system...
?
mi
from
Gainesville, GA
Click here to add this to my saved trials
1117 29th St S Ste 500
Great Falls, Montana 59405
(406) 731-8100
?
mi
from
Great Falls, MT
Click here to add this to my saved trials
Great Falls, Montana 59405
?
mi
from
Great Falls, MT
Click here to add this to my saved trials
?
mi
from
Great Falls, MT
Click here to add this to my saved trials
1101 26th Street South
Great Falls, Montana 59405
406.455.5000
Sletten Cancer Institute at Benefis Healthcare Benefis Hospitals has 516 beds at its two campuses...
?
mi
from
Great Falls, MT
Click here to add this to my saved trials
2475 Broadway St
Helena, Montana 59601
(406) 442-2480
St. Peter's Hospital Welcome to St. Peter’s Hospital, providing premier health care to a five–county...
?
mi
from
Helena, MT
Click here to add this to my saved trials
?
mi
from
Hines, IL
Click here to add this to my saved trials
1515 Holcombe Blvd
Houston, Texas 77030
 713-792-2121
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
?
mi
from
Houston, TX
Click here to add this to my saved trials
75 Claremont St Ste E
Kalispell, Montana 59901
(406) 752-7600
Glacier Oncology, PLLC Glacier Oncology are physician clinics focusing exclusively on the medical subspecialties of...
?
mi
from
Kalispell, MT
Click here to add this to my saved trials
310 Sunnyview Lane
Kalispell, Montana 59901
406) 752-5111
Kalispell Medical Oncology at KRMC Our commitment to integrating modern treatment programs with highly-trained physicians...
?
mi
from
Kalispell, MT
Click here to add this to my saved trials
310 Sunnyview Ln
Kalispell, Montana 59901
(406) 752-5111
Kalispell Regional Medical Center Nestled in the beautiful Flathead Valley of Northwestern Montana, Kalispell Regional...
?
mi
from
Kalispell, MT
Click here to add this to my saved trials
?
mi
from
Kearney, NE
Click here to add this to my saved trials
Missoula, Montana 59801
?
mi
from
Missoula, MT
Click here to add this to my saved trials
?
mi
from
Missoula, MT
Click here to add this to my saved trials
?
mi
from
Missoula, MT
Click here to add this to my saved trials
500 W Broadway St
Missoula, Montana 59802
(406) 543-7271
Montana Cancer Center at St. Patrick Hospital and Health Sciences Center St. Patrick Hospital is...
?
mi
from
Missoula, MT
Click here to add this to my saved trials
3535 N Bell School Rd
Rockford, Illinois 61114
(779) 696-9400
Swedish-American Regional Cancer Center The SwedishAmerican Regional Cancer Center offers state-of-the-art treatment and support services...
?
mi
from
Rockford, IL
Click here to add this to my saved trials
?
mi
from
Salem, OH
Click here to add this to my saved trials
?
mi
from
Sheridan, WY
Click here to add this to my saved trials
230 Nebraska St.
Sioux City, Iowa 51101
712-252-0088
Siouxland Hematology-Oncology Associates, LLP Siouxland Hematology-Oncology Associates (SHOA) provides medical oncology treatment. In addition to...
?
mi
from
Sioux City, IA
Click here to add this to my saved trials
801 5th St
Sioux City, Iowa 51104
(712) 279-2010
Mercy Medical Center - Sioux City Living the traditions, visions and values of the Sisters...
?
mi
from
Sioux City, IA
Click here to add this to my saved trials
2720 Stone Park Blvd
Sioux City, Iowa 51104
(712) 279-3500
St. Luke's Regional Medical Center St. Luke's is a patient and family-centered hospital that delivering...
?
mi
from
Sioux City, IA
Click here to add this to my saved trials
Wooster, Ohio 44691
?
mi
from
Wooster, OH
Click here to add this to my saved trials